Bibliografía del artículo
1. Marchiori P, Tobar S. La COVID-19 y las oportunidades de cooperación internacional en salud. Rev Cad Saúde Pública 36(4):1-3, 2020.
2. INEI. Estado de la población peruana 2020. Lima; 2020.
3. INEI. Perú: Factores de riesgo asociados a complicaciones por COVID-19, ENDES 2018 - 2019. Lima; 2020.
4. Quintanilla C, Zuñiga S. El efecto incretina y su participación en la diabetes mellitus tipo 2. Rev Med Inst Mex Seguro Soc 48(5):509-520, 2010.
5. Barchetta I, Ciccarelli G, Barone E, Cimini F, Ceccarelli V, Bertoccini L, et al. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 29:1087-1094, 2019.
6. Fernández C, Rysä J, Almgren P, Nilsson J, Engstrom G, Orho M, et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Int Med 284:377-387, 2018.
7. Fakhry AbdelMassih A, Ye J, Kamel A, Mishriky F, Ismail H, Ragab H, et al. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection. Obesity Medicine 19:100281, 2020.
8. de Oliveira M, de Sibio T, Solla Mathias L, Moretto Rodrigues B, Sakalem ME, Nogueira CR. Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture. Mol Cell Endocrinol 515:515917, 2020.
9. Das S, Anu K, Raosaheb Birangal S, Nitin Nikam A, Pandey A, Mutalik S. Joseph A. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Life Sci 258:118202, 2020.
10. Codo A, Gastao G, Monteiro L, Nakaya H, Farias A, Moraes P. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1a/glycolysis-dependent axis. Cell Metabolism 32:1-10, 2020.
11. Kalhotra P, Chittepu V, Osorio G, Gallardo T. Phytochemicals in garlic extract inhibit therapeutic enzyme DPP-4 and induce skeletal muscle cell proliferation: A possible mechanism of action to benefit the treatment of diabetes mellitus. Biomolecules 10(305):1-16, 2020.
12. Olalekan O, Opeyemi E, Orimoloye M, Sam O, Olalekan A, Gbadura I, Teixeira J. Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology 25:327-333, 2018.
13. Ayachi H, Merad M, Ghalem S. Study of interaction between dipeptidyl peptidase-4 and products extracted from the stevia plant by molecular modeling. Int J Pharm Sci Rev Res 23(1):87-90, 2013.
14. Kempegowda P, Zameer F, Kumar C, Prasad S, Kumar S. Inhibitory potency of Withania somnifera extracts against DPP-4: An in vitro evaluation. Afr J Tradit Complement Altern Med 15(1):11-25, 2018.
15. Ojeda M, Ardid A, Tomás S, Gimeno A, Cereto A, Beltrán R, et al. Ephedrine as a lead compound for the development of new DPP-4 inhibitors. Future Med Chem 9(18):2129-2146, 2017.
16. Ahmad I, Arifianti AE, Sakti AS, Saputri FC, Mun'im A. Simultaneous natural deep eutectic solvent-based ultrasonic-assisted extraction of bioactive compounds of cinnamon bark and sappan wood as a dipeptidyl peptidase IV inhibitor. Molecules (Basel, Switzerland) 25(17):E3832, 2020.
17. Chakrabarti R, Bhavtaran S, Narendra P, Varghese N, Vanchhawng L, Shihabudeen M, Thirumurgan K. Dipeptidyl peptidase-IV inhibitory activity of Berberis aristata. J Nat Prod 4:158-163, 2011.
18. Malik L, Ad'hiah A, Aziz G. Phytochemical contnt and the potential Punica granulatum peel extracts as radical scavengers and dipeptidyl peptidase-4 inhibitors. Journal of Biotechnology Research Center 13(1):5-11, 2019.
19. Riyanti S, Suganda A, Yulinah E. Dipeptidyl peptidase-IV inhibitory activity of some Indonesian medicinal plants. Asian J Pharm Clin Res 9(2):375-377, 2016.
20. Saleem S, Jafri L, ul Haq I, Chang L, Calderwood D, Green B, Mirza B. Plants Fagonia cretica L. y Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity. J Ethnopharmacol 156:26-32, 2014.
21. Gao Y, Zhang Y, Zhu J, Li B, Li1 Z, Zhu W, et al. Recent progress in natural products as DPP-4 inhibitors. Future Med Chem 7(8):1079-1089, 2015.
22. Kato E, Kawakami K, Kawabata J. Macrocarpal C isolated from Eucalyptus globulus inhibits dipeptidyl peptidase 4 in an aggregated form. J Enzyme Inhib Med Chem 33(1):106-109, 2018.
23. Kato E, Uenishi Y, Inagaki Y, Kurokawa M, Kawabata J. Isolation of rugosin A, B and related compounds as dipeptidyl peptidase-IV inhibitors from rose bud extract powder. Biosci Biotechnol Biochem 80(11):2087-2092, 2016.
24. Elmi A, Al-Jawad Sayem S, Ahmed M, Abdoul-Latif F. Natural compounds from djiboutian medicinal plants as inhibitors of COVID-19 by in silico investigations. Int J Curr Pharm Res 12(4):52-57, 2020.
25. Majumdar S, Mohanta BC, Chowdhury DR, Banik R, Dinda B, Basak A. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum. Curr Med Chem 17(19):2049-2058, 2010.
26. Tao H, Zhang Z, Shi J, Shao X, Cui D, Chi C. Template-assisted rational design of peptide inhibitors of furin using the lysine fragment of the mung bean trypsin inhibitor. FEBS J 273 (17):3907-3914, 2006.
27. Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Lu J. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience 23(6):101160, 2020.
28. Rangel-Méndez JA, Moo-Puc RE. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019. Future Microbiol 20221, 2020.
29. Figueredo A, Reyes F, Pérez M, Batista Y, Peña Y. Inhibidores de la dipeptidil peptidasa 4 y una nueva estrategia farmacológica en la diabetes mellitus tipo 2. Rev Cubana Med 55(3):239-256, 2016.
30. Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. COVID?19 and comorbilities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? J Diabetes 12(9):649-658, 2020.